<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04542811</url>
  </required_header>
  <id_info>
    <org_study_id>B.30.2.ATA.0.01.00/113</org_study_id>
    <nct_id>NCT04542811</nct_id>
  </id_info>
  <brief_title>Acupuncture In Migraine Without Aura Patients</brief_title>
  <official_title>Acupuncture For Preventing Of Attack Frequency And Improving Disability In Migraine Without Aura Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aimed to investigate the effect of acupuncture treatment on attack&#xD;
      frequency, pain intensity, and disability in migraine without aura patients who receive&#xD;
      prophylaxis treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acupuncture is a Traditional Chinese Medicine method that has been used for 3000 years to&#xD;
      control symptoms, treat illnesses, and relieve pain. Acupuncture is widely used in many&#xD;
      countries today as a complementary therapy, especially in cases of chronic pain. Migraine is&#xD;
      one of the diseases in which acupuncture treatment is commonly used. Studies conducted so far&#xD;
      have focused more on the effect of acupuncture on pain intensity in patients with migraine.&#xD;
      Data comparing the impact of acupuncture on both the attack frequency and disability in&#xD;
      migraine are relatively scarce.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Monthly attack frequency</measure>
    <time_frame>3 months</time_frame>
    <description>The participants will document the each migraine attack days in a month by pain free intervals of at least 48 hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of attacks</measure>
    <time_frame>3 months</time_frame>
    <description>Duration of the each migraine attack as hour</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain severity</measure>
    <time_frame>3 months</time_frame>
    <description>Pain severity during migraine attacks will be measured via visual analog scale (VAS). While 0 indicates no pain, 10 indicates the most severe pain imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disability</measure>
    <time_frame>3 months</time_frame>
    <description>Disability will measured via a questionnaire which is an ordinary rating scale to assess the migraine related disability of a patient with migraine. Migraine Disability Assessment (MIDAS) will be used. Migraine Disability Assessment (MIDAS) questionnaire is an ordinary rating scale to assess the migraine related disability of a patient with migraine. It is based on responses to five questions about disability associated with headache in the last three months. MIDAS questionnaire has four point grading system. Scores ranging from 0 to 5 indicates Grade 1 (little or none disability), scores ranging from 6 to 10 indicates Grade 2 (mild disability), scores ranging from 11 to 20 indicates Grade 3 (moderate disability), and scores 21 or greater indicates Grade 4 (severe disability).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Migraine Without Aura</condition>
  <condition>Acupuncture</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group will take 12 sessions of acupuncture addition to their prophylaxis treatment. Acupuncture points will be bilateral LI-4, LI-11, ST-8, ST-44, SP-6, GB-1, GB-14, GB-20, LR-3, and GV-14, GV-20. Sterile and single-use stainless steel acupuncture needles measuring 0.25x25 mm will be inserted to a depth of 10 mm and be retained for 30 minute without any further stimulation. Acupuncture will be performed by an acupuncturist with an acupuncture practitioner licence from the Turkish Ministry of Health. Adverse events will be monitored for all acupuncture sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group will take only their migraine prophylaxis treatment. Participants will followed-up 3 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture is a complementary therapy modality which is used by needle inserted the specific points on the body.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Being diagnosed with migraine according to IHS (International Headache Association)&#xD;
&#xD;
          -  Receiving migraine prophylaxis treatment&#xD;
&#xD;
          -  Having more than four attacks per month/more than one attack per week&#xD;
&#xD;
          -  Not having received acupuncture treatment before.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Being diagnosed with migraine with aura/secondary headache&#xD;
&#xD;
          -  Having received acupuncture treatment for any reason within the last year&#xD;
&#xD;
          -  Not giving consent for acupuncture treatment&#xD;
&#xD;
          -  Having a fear of needles.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasemin Çayır</last_name>
    <role>Study Director</role>
    <affiliation>Ataturk University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rabia Rukiye Akinci</name>
      <address>
        <city>Erzurum</city>
        <zip>25040</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 2, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2020</study_first_posted>
  <last_update_submitted>September 11, 2020</last_update_submitted>
  <last_update_submitted_qc>September 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Yasemin Cayir</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <keyword>migraine</keyword>
  <keyword>acupuncture</keyword>
  <keyword>MIDAS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Migraine without Aura</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

